Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127217) titled 'A Multicenter, Randomized, Crossover, Placebo-Controlled, Superiority Clinical Trial Protocol to Evaluate the Efficacy and Safety of cellulose enhancing capsules' on June 26.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Shanghai Tenth People's Hospital

Condition: Overweight and Obesity

Intervention: Experimental group:receives a cellulose enhancing capsules (composed of cross-linked hydrogel particles and a gelatin capsule shell)

Recruitment Status: Not Recruiting

Phase: 3

Date of First Enrollment: 2025-05-15

Target Sample Size: Experimental group:90;Control group:90;

Co...